Publication | Open Access

Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach

Medicinal ChemistryDrug TargetBiochemistryNatural SciencesMedicineRational Drug DesignArginine Methyltransferase InhibitorsPeptide SynthesisProtein EngineeringSelective ClassDrug DevelopmentPharmacologyDrug Discovery